Cargando…
Hypercalcitoninemia is not Pathognomonic of Medullary Thyroid Carcinoma
Hypercalcitoninemia has frequently been reported as a marker for medullary thyroid carcinoma. Currently, calcitonin measurements are mostly useful in the evaluation of tumor size and progression, and as an index of biochemical improvement of medullary thyroid carcinomas. Although measurement of calc...
Autores principales: | Toledo, Sergio PA, Lourenço, Delmar M, Santos, Marcelo Augusto, Tavares, Marcos R, Toledo, Rodrigo A, de Menezes Correia-Deur, Joya Emilie |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710445/ https://www.ncbi.nlm.nih.gov/pubmed/19606248 http://dx.doi.org/10.1590/S1807-59322009000700015 |
Ejemplares similares
-
Sporadic Medullary Thyroid Carcinoma: Clinical Data From A University Hospital
por: Correia-Deur, Joya Emilie M., et al.
Publicado: (2009) -
Surgical approach to medullary thyroid carcinoma associated with multiple endocrine neoplasia type 2
por: Tavares, Marcos R., et al.
Publicado: (2012) -
Exploring the role of technitium-99m dimercaptosuccinyl acid (V) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomography
por: Krishnamurthy, Arvind, et al.
Publicado: (2014) -
A differential diagnosis of inherited endocrine tumors and their tumor counterparts
por: Toledo, Sergio P. A., et al.
Publicado: (2013) -
Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility
por: Toledo, Rodrigo A, et al.
Publicado: (2015)